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A B S T R A C T
The extent of the regression of duodenal gastric metaplasia (DGM) after the eradica-
tion of Helicobacter pylori infection is controversial. Therefore, we decided to assess the
degree of DGM before, sex weeks and one year after H. pylori eradication. 105 consecu-
tive Helicobacter pylori positive patients with endoscopically proven duodenal ulcer,
with DGM and Helicobacter pylori infection were recruited for this study. The diagnosis
of Helicobacter pylori infection was based on CLO-test and histology, and DGM was as-
sessed on four bulb biopsies taken before, sex weeks and one year after Helicobacter
pylori eradication. Histological assessment of Helicobacter pylori associated gastritis
was performed according to the Sydney classification. Follow up study on 98 patients
before, six weeks and one year after the eradication of Helicobacter pylori showed that
the mean extent of DGM did not change significantly after eradication and did not dif-
fer when compared with 14 patients with persisting infection. Our results show that the
inflammatory process related to Helicobacter pylori does not play the main role in the
development of DGM.
Introduction
Helicobacter pylori (H. pylori) is a
Gram-negative spiral organism that colo-
nizes human gastric mucosa and is the
major cause of gastritis. Duodenal gastric
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metaplasia (DGM) is the appearance of
patches of gastric type mucous cells inter-
spersed between the duodenal epithelial
cells. It is assumed that DGM is the re-
sult of persistently high concentrations of
acidity in the duodenal bulb and is com-
monly found in biopsy specimens from
patients with duodenitis and duodenal
ulcer disease. It is already known that H.
pylori positive antral gastritis leads to in-
creased output of gastric acid thus lead-
ing to increased exposure of duodenal
mucosa to acid in some patients. In that
context, DGM is an adaptive defense re-
sponse on the duodenal bulb to high con-
centration of acidity1,2. However, DGM
may also develop as a non-specific re-
sponse to mucosal injury not associated
with acid peptic damage3.
As H. pylori colonization is restricted
to gastric type epithelium, the presence of
gastric metaplasia in the duodenum
would allow H. pylori to colonize the mu-
cosa and to produce active inflammation.
This may ultimately lead to ulceration.
Thus, both H. pylori infection and DGM
are considered to be prerequisites for the
development of H. pylori induced duode-
nitis4.
It might be anticipated that the eradi-
cation of H. pylori infection and the con-
sequent normalization on the acid secre-
tion would induce regression of DGM.
However, the data on the regression of
DGM after Helicobacter pylori eradica-
tion are controversial5–7. The aim of this
study was to assess the extent of DGM
and to assess five main histological fea-
tures of gastritis in gastric mucosa before
and after H. pylori eradication in a one
year follow up period.
Material and Methods
Subjects
146 consecutive patients of either sex
at least 18 years of age, with dyspeptic
symptoms, referred to Endoscopic Ser-
vices for diagnostic upper gastrointesti-
nal endoscopy, and whose diagnosis was
duodenal ulcer were considered for the
study. Among these, 105 met all three in-
clusion criteria (H. pylori positive duode-
nal ulcer and duodenal gastric metapla-
sia).
Patients with a history of hemorrhagic
diathesis or coagulation defects, malig-
nancy of esophagus, stomach or duode-
num as well as patients who underwent
gastric surgery and those having insulin
dependent diabetes mellitus were exclud-
ed from the study. Pregnant or lactating
women were also excluded. No acid sup-
pressants, antibiotics, nonsteroidal anti-
inflammatory drugs or corticosteroids in
the past month had been taken. The Eth-
ics Committee approved the study and all
patients gave written informed consent.
Clinical methods
At each endoscopy, four corpus and
three antrum biopsy specimens were ob-
tained with standard biopsy forceps for
histopathological examination. In addi-
tion one antrum and one corpus biopsy
specimens were processed according to
standard procedures for H. pylori culture.
At the inclusion endoscopy, a CLO test
(Delta West, Bentley, Australia) was also
performed using one antrum and one cor-
pus biopsy. To grade the extent of DGM,
four duodenal bulb biopsy specimens
were obtained at the margin of the ulcer
and at least 1 cm away from the pylorus.
Specimens were placed in buffered formal
saline and processed for histological ex-
amination. All patients were treated with
pantoprazole 40 mg, metronidazole 500
mg, amoxycillin a 1000 mg. All drugs
were administered together, twice daily
after breakfast and dinner during the
seven days and pantoprazole 40 mg o.d.
was continued during the three more
weeks. Re-endoscopy was performed six
weeks and one year after the triple ther-
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apy. Gastric biopsies were repeated, ta-
ken from sites similar to those in the ini-
tial endoscopy, and four duodenal biopsy
specimens were obtained from the center
of the scar. The patients were considered
H. pylori positive if two of the tests per-
formed were positive and successfully
eradicated if all tests were negative.
Histological methods
Biopsy specimen sections were stained
with hematoxylin and eosin to detect H.
pylori and gastritis. Sections from duode-
nal biopsy specimens were stained with
alcan blue periodic acid-Shiff (pH 2.5) to
evaluate gastric metaplasia. Duodenal
gastric metaplasia was defined as the oc-
currence of foci of gastric epithelial cells
containing apical periodic acid-Schiff-po-
sitive mucin together with the absence of
a brush border. The extent of DGM was
scored according to Patrick et al.8 as fol-
lows: grade 0 (none), no gastric metapla-
sia; grade 1 (focal type), wherein mu-
cus-containing cells replaced normal epi-
thelial cells in a localized area; grade 2
(multifocal type), when two or more in-
volved areas were separated by normal
epithelium; grade 3 (diffuse type), when
diffuse involvement was present. The his-
tological features of pre- and post- treat-
ment gastric mucosa were reviewed and
categorized according to the Sydney sys-
tem9, i.e. severity of a) chronic and b)
acute inflammation, c) atrophy of the mu-
cosa, d) presence of intestinal metaplasia
and e) density of H. pylori by Giemsa
staining, and graded on scale from 0 to 3.
Statistical methods
The changes of grade of duodenal gas-
tric metaplasia in cure patients were eva-
luated with Friedman  2 test.
The sign test was used to calculate the
statistical difference in extent of duode-
nal gastric metaplasia in cured patients.
All statistical analysis was performed
in SAS6.12.
The changes of grade of gastritis be-
fore and one year after Helicobacter py-
lori eradication were evaluated with chi-
square test.
Results
We recruited 146 patients but 105 pa-
tients meet the inclusion criteria (H. py-
lori positive patients with duodenal ulcer
and DGM). H. pylori infection was con-
firmed in 122 out of 146 duodenal ulcer
patients (84%), and DGM was present in
128 patients (88%). The results were sim-
ilar to our previous study10. All of 105 H.
pylori positive patients with duodenal ul-
cer and DGM have no active ulcer at the
time of re-endoscopy. H. pylori was suc-
cessfully eradicated in 91 patients (87%).
There was no significant difference be-
tween eradicated and no eradicated
group with respect to age, sex, and smok-
ing (Table 1). 7 of patient were lost during
the one year follow-up period. 98 patients
underwent the third endoscopy at one
year. 7 patients (7%) dropped out from
the study for the following reasons: lost to
follow up (n=4), adverse events (n=2), re-
fused endoscopy (n=1). Two of five pa-
tients that required an additional endos-
copy because of dyspeptical symptoms
have relapse of ulcer and were excluded
from the study (Table 2).
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TABLE 1
CHARACTERISTICS OF PATIENTS
INCLUDED IN THE STUDY
Number of patients 146
Median age 53.2 (29–74)
Gender (M/F) 85 / 61
Smokers/nonsmokers 69 / 77
HP+/HP– 122 (84%) / 24 (16%)
DGM+/DGM– 128 (88%) / 18 (16%)
DGM+and HP+ 105 (72%)
DGM = duodenal gastric metaplasia;
HP = Helicobacter pylori
Changes of extent of DGM
There was no statistical significant
difference in the grade of DGM (Fried-
man test: df = 2, Q= 3.767, p=0.152) in the
cure group of patients after the six weeks
and one year period. Looking separately
each of the patients in the cure group
(n=91), the grade of DGM was not chan-
ged in 61/91 (67%), improved in 20/91
(22%) and worsened in 10/91 (11%).
Between the patients with improved
and worsened DGM was not statistical
significant difference according to the sign
test (p=0,18).
After the one year 30/81 (37%) cured
patients have not changed DGM, 35/81
(43%) improved and 15/81 (19%) wors-
ened.
One year after the Helicobacter pylori
eradication there was not statistical sig-
nificant difference between the patients
with the improved the DGM and those
with worsened (p=0.23) (Tables 3–5).
Changes of gastritis
H. pylori density, acute and chronic in-
flammation showed statistically signifi-
cant differences between pre- and post-
560
J. Bago et al.: Helicobacter Pylori Eradication, Coll. Antropol. 26 (2002) 2: 557–563
TABLE 2
CHANGES OF EXTENT OF DGM ACCORDING TO THE NUMBER OF PATIENTS BEFORE
AND AFTER THE THERAPY









0 105 51 40 14 / /
6 weeks 97 50 33 14 2 6
1 year 90 45 34 11 5 2
DGM = duodenal gastric metaplasia
TABLE 3








0 3 1 4
I 38 4 35
II 2 1 2
III 1 0 1
lost 1 0 2
DGM = duodenal gastric metaplasia;
HP– = Helicobacter pylori eradicated;
HP+ = Helicobacter pylori non-eradicated
TABLE 4








0 1 0 1
I 5 3 2
II 25 2 24
III 3 1 4
lost 0 0 2
DGM = duodenal gastric metaplasia;
HP– = Helicobacter pylori eradicated;
HP+ = Helicobacter pylori non-eradicated
TABLE 5








0 1 0 0
I 0 0 3
II 2 1 2
III 8 1 6
lost 1 0 0
DGM = duodenal gastric metaplasia;
HP– = Helicobacter pylori eradicated;
HP+ = Helicobacter pylori non-eradicated
treatment biopsy specimens (p<0.001),
and not statistically significant change
were observed for the degree of atrophy
and presence of intestinal metaplasia
(p>0.05) (Table 6).
Discussion
DGM is almost constant finding in pa-
tients with duodenal ulcer. It s considered
to be an acquired condition to high acid
exposure11.
While up to date reports about influ-
ence of H. pylori eradication on DGM are
still conflicting we tried to investigate
changes of grades of DGM in every pa-
tients with duodenal ulcer, separately du-
ring the six weeks and one year after the
H. pylori eradication.
Assess of even minimal change in
DGM in every patient separately after
the Helicobacter pylori eradication was
the primary goal of our study.
Our results show that there was no
statistical significant difference in the
grade of DGM after six weeks and one
year in the group of Helicobacter pylori
eradicated patients. Even more, statisti-
cal significant difference was not reached
in the patients with improved and wors-
ened extent of DGM.
Kim et al.12 find that initial preva-
lence and initial extent of DGM in duode-
nal ulcer patients one year after the He-
licobacter pylori eradication did not chan-
ge. Four years after the Helicobacter
pylori eradication, in the former study
there was not statistical significant dif-
ference in the extent of DGM. It has been
observed that patients with duodenal ul-
cer followed for five years after the Heli-
cobacter pylori eradication have not de-
crease in DGM.
Their observations show that one-year
follow up of patients is probably enough
and it is not to be expected that our re-
sults would be significant change after
the three more years. In agreement with
our results Noach et al.5 showed that
there was no statistical significant differ-
ence of DGM one-year after the Heli-
cobacter pylori eradication. Harris et al.6
excluded any significant changes in prev-
alence and the extent of DGM six months
after the Helicobacter pylori eradication.
In the study by Savarino et al.13 gas-
tric acid output and DGM did not change
significantly one year after the Helico-
bacter pylori eradication in patients with
duodenal ulcer thus fail to confirm that
DGM is an adoptive response to high con-
centration of acidity in duodenal bulb.
Therefore the DGM was also unchanged.
By contrast, Khulusi et al.7,14 showed
reduction of DGM as the exclusive result
of the Helicobacter pylori eradication.
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TABLE 6
EXTENT OF THE GRADE OF GASTRITIS BEFORE AND AFTER H. PYLORI ERADICATION
No. of patients
path. parameter 0 1 2 3
before after before after before after before after p
Chronic inflammation 1 10 22 57 53 20 12 3 <0.05
Acute inflammation 15 57 43 25 25 6 7 2 <0.05
H. pylori density 0 59 29 24 36 6 25 1 <0.05
Atrophy 54 50 22 30 12 8 2 2 >0.05
Intestinal metaplasia 71 71 12 13 6 5 1 1 >0.05
 2 test
An important problem in the DGM de-
tection is its patchy distribution. In addi-
tion Wyatt et al.3 could not find the signif-
icant difference between the extent of
DGM at sites around the ulcer craters of
scars and macroscopically normal appea-
ring mucosa. To exclude possible biopsy
sampling error we took four duodenal
mucosa biopsy specimens at the margin
of the ulcer and at least 1cm away from
the pylorus at the beginning of the study.
After the Helicobacter pylori eradication
we took biopsies from a topographic sites
similar to that in the initial endoscopy
and four addition biopsy specimens from
the center of the scar.
In opposite to acute inflammation,
chronic inflammation and Helicobacter
pylori density atrophy of gastric mucosa
and intestinal metaplasia did not change
significantly after the Helicobacter pylori
eradication in one year follow up. Simi-
larly results were observed by others15.
In conclusion we failed to confirm the
positive relationship between Helicobac-
ter pylori infection and extent of DGM.
This result may be explained by the fact
the recurred patients have natural high
acid output and that the decreased acid
output caused by Helicobacter pylori era-
dication may not be enough to bring re-
versal change of DGM after one year.
Secondly, it is possible that the follow
up interval was too short to detected sig-
nificant decrease in the prevalence of the
extent of DGM after the Helicobacter py-
lori eradication. Thirdly, after the Helico-
bacter pylori eradication fail in acid out-
put may not have been sufficed to affect
DGM.
Chronic mucosal inflammation caused
by Helicobacter pylori infection which
leads to gastric mucosa atrophy and in-
testinal mataplasia persist one year after
the Helicobacter pylori eradication thus
potentially lead to the gastric carcinoma.
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U^INAK ERADIKACIJE HELICOBACTER PYLORI NA VELI^INU
DUODENALNE @ELU^ANE METAPLAZIJE I NA STUPANJ GASTRITISA
S A @ E T A K
Opseg `elu~ane duodenalne metaplazije (D@M) i njezina regresija poslije eradika-
cije Helicobacter pylori je dvojbena. Stupanj D@M pratili smo prije eradikacije, te {est
tjedana i jednu godinu poslije eradikacije Helicobacter pylori. U studiju smo uklju~ili
105 bolesnika s endoskopski verificiranim duodenalnim vrijedom, D@M te infekcijom s
Helicobacter pylori. Infekciju s Helicobacter pylori dokazivali smo s CLO-testom i his-
tolo{ki, a D@M je odre|ivana patohistolo{ki u ~etiri biopti~ka materijala iz bulbusa
dvanaesnika prije eradikacije, {est tjedana i jednu godinu nakon eradikacije Helico-
bacter pylori. Gastritis s Helicobacter pylori pozitivnim nalazom podijeljen je prema
Sydneyskoj klasifikaciji. U 98 bolesnika prije eradikacije, {est tjedana i jednu godinu
nakon eradikacije Helicobacter pylori, nije prona|ena zna~ajnija promjena u opsegu
D@M. Isto tako, nije bilo zna~ajnije razlike u stupnju D@M u usporedbi s 14 bolesnika
kod kojih nije uspjela eradikacija Helicobacter pylori. Na{i rezultati pokazuju da upal-
ni proces izazvan s Helicobacter pylori nema presudnu ulogu u nastanku D@M.
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